Entrada Therapeutics shares owned by Credit Suisse
Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Credit Suisse
from 13F filings
Historical chart of Credit Suisse investment in Entrada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Entrada Therapeutics held by Credit Suisse consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Entrada Therapeutics by Credit Suisse
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $239k | 16k | 15.09 |
| 2023-09-30 | $261k | 17k | 15.80 |
| 2023-06-30 | $260k | 17k | 15.14 |
| 2023-03-31 | $180k | 12k | 14.50 |
| 2022-12-31 | $119k | 8.8k | 13.52 |
| 2022-06-30 | $0 | 6 | 0.00 |